ovulanta 1 kit
mankind - clomiphene - kit - 300mg - 1
ovulant 50mg tablet
totalcare pharma inc - clomifene citrate - tablet - 50mg
ovulant 50 mg tablet
aldril pharmaceuticals, inc. - clomifene citrate - tablet - 50 mg
solcovagin 537mg/ml+20,4mg/ml+58,6mg/ml+6mg/ml solution for topical use
legacy pharmaceuticals switzerland gmbh - nitric acid 70%, glacial acetic acid, oxalic acid dihydrate, zinc nitrate hexahydrate - solution for topical use - 537mg/ml+20,4mg/ml+58,6mg/ml+6mg/ml
solcovagin solution for topical use
legacy pharmaceuticals switzerland gmbh - nitric acid 70%, glacial acetic acid, oxalic acid dihydrate, zinc nitrate hexahydrate - solution for topical use - 537mg/ml+ 20,4mg/ml+ 58,6mg/ml+ 6mg/ml
ovuplant
virbac (australia) pty ltd - deslorelin as deslorelin acetate - parenteral implant, device - deslorelin as deslorelin acetate ungrouped active 2.1 mg/im - endocrine system - horse mare (female) | female horse - induction of ovulation
ovestin ovula 0.5mg pessary strip pack
aspen pharmacare australia pty ltd - estriol, quantity: 0.5 mg - pessary, moulded - excipient ingredients: hard fat; cetomacrogol 1000; glyceryl ricinoleate - vulvo-vaginal complaints due to oestrogen deficiency associated with the climacteric and the postmenopause or after ovariectomy - atrophic vaginitis; - pruritus vulvae; - dyspareunia due to vulvo-vaginal atrophy; - as auxillary therapy in the treatment of vaginal infections - as pre-operative therapy for vulvo-vaginal surgery and during subsequent convalescence; - ulcers in cases of prolapse of the uterus or vagina; - to avoid misinterpretation of a cytological smear.
cordx ovulation & pregnancy test combo device
belmed trading united states of america - 30 tests (20 ovulation tests & 10 pregnancy tests) - device - device - n/a
cordx ovulation & pregnancy test combo
70 tests (50 ovulation tests & 20 pregnancy tests) -
ovitrelle
merck europe b.v. - choriogonadotropin alfa - anovulation; reproductive techniques, assisted; infertility, female - sex hormones and modulators of the genital system, - ovitrelle is indicated in the treatment of:women undergoing superovulation prior to assisted reproductive techniques such as in vitro fertilisation (ivf): ovitrelle is administered to trigger final follicular maturation and luteinisation after stimulation of follicular growth;anovulatory or oligo-ovulatory women: ovitrelle is administered to trigger ovulation and luteinisation in anovulatory or oligo-ovulatory patients after stimulation of follicular growth.